mounjaro eli lilly tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly says India response

Visible particles or flakes

Patients beginning tirzepatide treatment may be addressing multiple health concerns simultaneously, making it difficult to isolate specific causes of new or worsening ED symptoms

doi: 10.3168/jds.2006-811 55 SchusterSEwaldJKaletaC

Body weight, insulin resistance severity, and metabolic goals also influence starting-dose selection

As noted above, a large majority (86%) initially supports this policy change

The reality check: the FDA does not consider it a legal cosmetic or dietary ingredient, and there is real concern that long-term use raises the risk of melanoma (skin cancer) the opposite of what most people assume a tan in a vial would do for skin safety (WebMD)